Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,374,201 | 5,531,717 | 5,959,772 | 9,082,486 | 5,929,296 |
| Marketable Securities | 242,484 | 234,252 | 272,363 | 344,021 | 351,974 |
| Receivables | 6,653,830 | 8,074,384 | 7,816,509 | 7,639,511 | 7,957,843 |
| Inventories | 7,139,651 | 7,129,632 | 7,090,247 | 7,086,481 | 7,097,779 |
| Other current assets | 1,395,294 | 1,382,825 | 1,396,879 | 1,348,691 | 3,782,448 |
| TOTAL | $21,805,460 | $22,352,810 | $22,535,770 | $25,501,190 | $25,119,340 |
| Non-Current Assets | |||||
| PPE Net | 13,143,570 | 13,285,260 | 13,214,770 | 13,666,820 | 13,086,150 |
| Investments And Advances | 2,946,346 | 3,204,028 | 3,409,397 | 3,274,490 | 3,610,090 |
| Intangibles | 70,046,840 | 71,544,620 | 72,029,840 | 74,664,420 | 72,782,660 |
| Other Non-Current Assets | 3,804,764 | 3,911,762 | 3,991,073 | 4,268,640 | 3,348,670 |
| TOTAL | $89,941,520 | $91,945,670 | $92,645,080 | $95,874,370 | $92,827,570 |
| Total Assets | $111,747,000 | $114,298,500 | $115,180,800 | $121,375,600 | $117,946,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,081,837 | 1,955,463 | 220,875 | 208,238 | 2,730,950 |
| Accounts payable and accrued liabilities | 3,090,428 | 3,063,060 | 2,917,869 | 3,232,077 | 3,138,989 |
| Other current liabilities | 10,117,290 | 10,730,710 | 10,564,540 | 11,862,630 | 10,153,940 |
| TOTAL | $15,921,440 | $17,460,630 | $14,967,370 | $16,667,850 | $17,327,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 37,241,060 | 36,549,910 | 39,872,460 | 43,364,250 | 42,879,110 |
| Other Non-Current Liabilities | 6,748,249 | 6,855,139 | 7,108,182 | 7,574,764 | 7,671,669 |
| TOTAL | $48,905,500 | $48,386,170 | $51,982,020 | $56,042,240 | $56,080,810 |
| Total Liabilities | $64,826,930 | $65,846,800 | $66,949,380 | $72,710,090 | $73,408,410 |
| Shareholders' Equity | |||||
| Common Shares | 14,751,110 | 15,253,990 | 15,189,040 | 15,680,560 | 16,014,190 |
| Retained earnings | 12,908,950 | 14,115,460 | 14,255,200 | 14,193,120 | 12,543,050 |
| Other shareholders' equity | 5,122,430 | 4,108,140 | 3,861,420 | 3,480,590 | 438,170 |
| TOTAL | $46,920,040 | $48,451,680 | $48,231,450 | $48,665,460 | $44,538,510 |
| Total Liabilities And Equity | $111,746,970 | $114,298,480 | $115,180,830 | $121,375,550 | $117,946,920 |